Belgium - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)
Since 2014, Belgium Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) rose 3.9% year on year. In 2019, the country was number 4 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) at €420.62 Per Capita. Belgium is overtaken by Liechtenstein, which was number 3 at €522.2 Per Capita and is followed by France with €412.39 Per Capita. Switzerland topped the ranking with €665.57 Per Capita in 2019, that is an increase of 3.2% versus 2018. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal recorded the worst performance at -12.9% per year.
| Date | Euros Per Capita |
|---|---|
| 2019 | 420.62 |
| 2018 | 419.13 |
| 2017 | 393.34 |
| 2016 | 376.07 |
| 2015 | 366.58 |
How does Belgium rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?
| # | 23 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
665.57 | 2019 | +3.1 % | +5.3 % | View data |
| 2 |
#2
Germany
|
524.79 | 2019 | +2.3 % | +3.0 % | View data |
| 3 |
#3
Liechtenstein
|
522.20 | 2019 | +3.4 % | +0.9 % | View data |
| 4 |
#4
Belgium
|
420.62 | 2019 | +0.4 % | +3.9 % | View data |
| 5 |
#5
France
|
412.39 | 2019 | +0.6 % | +1.9 % | View data |